Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62.7M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$43.7M |
| 3 |
AvalonBay Communities
AVB
|
+$36.7M |
| 4 |
Simon Property Group
SPG
|
+$36.4M |
| 5 |
AGNC Investment
AGNC
|
+$35.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$52.7M |
| 2 |
Cencora
COR
|
+$39.6M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$35.8M |
| 4 |
TLM
TALISMAN ENERGY INC
TLM
|
+$30M |
| 5 |
Ecolab
ECL
|
+$29.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.29% |
| 2 | Technology | 14.5% |
| 3 | Industrials | 10.63% |
| 4 | Consumer Discretionary | 9.8% |
| 5 | Consumer Staples | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$423B
| $228M | 0.59% |
5,668,128
+268,600
| +5% | +$11.7M |
|
27
UnitedHealth
UNH
$370B
| $228M | 0.59% |
1,867,727
+57,700
| +3% | +$6.83M |
|
28
Cisco
CSCO
$479B
| $226M | 0.59% |
8,236,093
+446,200
| +6% | +$12.8M |
|
29
Bristol-Myers Squibb
BMY
$132B
| $209M | 0.54% |
3,138,552
+129,100
| +4% | +$8.51M |
|
30
Comcast
CMCSA
$90B
| $207M | 0.54% |
6,876,968
+325,400
| +5% | +$9.55M |
|
31
CVS Health
CVS
$122B
| $201M | 0.52% |
1,913,410
+63,400
| +3% | +$6.48M |
|
32
Philip Morris
PM
$295B
| $200M | 0.52% |
2,495,831
+129,300
| +5% | +$10.6M |
|
33
Amgen
AMGN
$222B
| $189M | 0.49% |
1,231,508
+65,900
| +6% | +$10.6M |
|
|
AGN
34
DELISTED
Allergan plc
AGN
| $189M | 0.49% |
622,636
+30,100
| +5% | +$8.98M |
|
35
Canadian National Railway
CNI
$76.6B
| $188M | 0.49% |
3,248,100
+123,000
| +4% | +$7.71M |
|
36
AbbVie
ABBV
$435B
| $187M | 0.48% |
2,782,329
+355,211
| +15% | +$23.2M |
|
37
Altria Group
MO
$114B
| $183M | 0.47% |
3,731,894
+134,600
| +4% | +$6.82M |
|
38
SLB Ltd
SLB
$75B
| $178M | 0.46% |
2,061,775
+101,500
| +5% | +$9.16M |
|
39
Medtronic
MDT
$112B
| $175M | 0.45% |
2,361,063
+100,800
| +4% | +$7.7M |
|
40
Eli Lilly
LLY
$1.06T
| $175M | 0.45% |
2,090,243
+59,600
| +3% | +$4.54M |
|
|
41
Qualcomm
QCOM
$176B
| $167M | 0.43% |
2,661,465
-772,700
| -23% | -$52.7M |
|
42
Abbott
ABT
$187B
| $166M | 0.43% |
3,387,818
+86,500
| +3% | +$4.15M |
|
43
Enbridge
ENB
$112B
| $160M | 0.41% |
3,404,800
+181,800
| +6% | +$9.03M |
|
44
Suncor Energy
SU
$70.3B
| $160M | 0.41% |
5,777,164
+265,900
| +5% | +$8.04M |
|
45
Boeing
BA
$185B
| $159M | 0.41% |
1,143,291
+57,600
| +5% | +$8.4M |
|
46
3M
MMM
$94.3B
| $158M | 0.41% |
1,224,828
+115,653
| +10% | +$15.5M |
|
47
Mastercard
MA
$493B
| $157M | 0.41% |
1,681,420
+83,800
| +5% | +$7.69M |
|
48
Starbucks
SBUX
$120B
| $157M | 0.41% |
2,929,044
+110,900
| +4% | +$5.63M |
|
49
Biogen
BIIB
$30.7B
| $153M | 0.4% |
378,599
+18,800
| +5% | +$7.55M |
|
50
Automatic Data Processing
ADP
$108B
| $153M | 0.4% |
1,900,885
-43,600
| -2% | -$3.72M |
|
Similar funds
Swiss National Bank's Q2 2015 Portfolio in Review
As of Q2 2015, Swiss National Bank held 2,650 positions worth $38.6B, up 3% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $1.55B of net new capital in Q2 2015, opening 104 new positions and adding to 1,775 existing holdings. Its largest new stake was Aramark: 434,198 shares worth $9.71M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Qualcomm, an estimated $52.7M trimmed.
- Swiss National Bank's largest Q2 2015 buy was Aramark: 434,198 shares worth $9.71M.
- Swiss National Bank added most to Apple in Q2 2015, an estimated $62.7M increase.
- Swiss National Bank's biggest Q2 2015 reduction was Qualcomm, cutting an estimated $52.7M.
- Swiss National Bank fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $35.8M.
- Swiss National Bank's ten largest holdings make up 14% of its $38.6B portfolio in Q2 2015.
- Swiss National Bank opened 104 new positions and closed 70 in Q2 2015.
- Swiss National Bank's portfolio value rose 3% quarter-over-quarter to $38.6B.
Based on Swiss National Bank's 13F filing for Q2 2015, filed 5 Aug 2015.